Literature DB >> 8883193

Chondroitinase ABC (pharmaceutical grade) for chemonucleolysis. Functional and structural evaluation after local application on intraspinal nerve structures and blood vessels.

K Olmarker1, J Strömberg, J Blomquist, P Zachrisson, U Nannmark, C Nordborg, B Rydevik.   

Abstract

STUDY
DESIGN: The effects on nerve tissue and blood vessels of locally applied chondroitinase ABC were studied in two experimental models using chymopapain and the vehicle of chondroitinase ABC for controls.
OBJECTIVES: To assess the effects of chondroitinase ABC on blood vessels and nerve tissue after local application. SUMMARY OF BACKGROUND DATA: Chondroitinase ABC has been suggested for chemonucleolysis because it has a high specificity for nucleus pulposus matrix, which could mean a high efficiency in dissolving disc tissue combined with a low risk of side effects on other tissues.
METHODS: Chondroitinase ABC or controls were injected intrathecally in the pig, and nerve conduction velocity and histologic changes were assessed after 7 days. The same substances were injected into the hamster cheek pouch and studied for 60 minutes for microvascular effects. The vehicle for the enzyme was used as a negative control and chymopapain in a therapeutic concentration served as a positive control.
RESULTS: In all series there was a slight intrathecal fibrotic reaction that was most pronounced after chymopapain injection. The effects on nerve conduction velocity and nerve morphology were similar between chondroitinase ABC and its vehicle. Chymopapain induced a significant reduction in nerve conduction velocity and pronounced histologic changes. In the cheek pouch, chymopapain induced a stand-still of blood flow at the injection site, and microhemorrhage and macromolecular leakage from the vessels at the border of the injection site. Only a slightly reduced blood flow was occasionally found after injection of chondroitinase ABC and controls.
CONCLUSIONS: In agreement with the current literature, these observations indicate that chondroitinase ABC is safe regarding adverse effects on nerve tissue and blood vessels. The slight reduction in conduction velocity after intrathecal injection of chondroitinase ABC or its vehicle is most likely the result of surgical injury while releasing the nerve roots from the intrathecal fibrous adhesions. Such adhesions may be related to the laminectomy per se, and probably have no pathophysiologic significance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8883193     DOI: 10.1097/00007632-199609010-00002

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  4 in total

1.  Axonal regeneration into acellular nerve grafts is enhanced by degradation of chondroitin sulfate proteoglycan.

Authors:  C A Krekoski; D Neubauer; J Zuo; D Muir
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

2.  Synergistic effects of bone mesenchymal stem cells and chondroitinase ABC on nerve regeneration after acellular nerve allograft in rats.

Authors:  Ying Wang; Hua Jia; Wen-Yuan Li; Xiao-Jie Tong; Gui-Bo Liu; Si-Wen Kang
Journal:  Cell Mol Neurobiol       Date:  2011-11-18       Impact factor: 5.046

3.  Chemonucleolysis with Chondroitin Sulfate ABC Endolyase for Treating Lumbar Disc Herniation: Exploration of Prognostic Factors for Good or Poor Clinical Outcomes.

Authors:  Katsuhiko Ishibashi; Muneyoshi Fujita; Yuichi Takano; Hiroki Iwai; Hirohiko Inanami; Hisashi Koga
Journal:  Medicina (Kaunas)       Date:  2020-11-19       Impact factor: 2.430

4.  Efficacy and Safety of Condoliase Disc Administration as a New Treatment for Lumbar Disc Herniation.

Authors:  Masahiro Inoue; Takeshi Sainoh; Atsushi Kojima; Masatsune Yamagata; Tatsuo Morinaga; Chikato Mannoji; Hiromi Ataka; Masaomi Yamashita; Hiroshi Takahashi; Junya Saito; Takayuki Fujiyoshi; Tetsuhiro Ishikawa; Yawara Eguchi; Kei Kato; Sumihisa Orita; Kazuhide Inage; Yasuhiro Shiga; Masaki Norimoto; Tomotaka Umimura; Yuki Shiko; Yohei Kawasaki; Yasuchika Aoki; Seiji Ohtori
Journal:  Spine Surg Relat Res       Date:  2021-06-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.